Skip to main content
Premium Trial:

Request an Annual Quote

Gyros Licenses Technology to Cellectricon

 

NEW YORK, April 14 - Gyros of Uppsala, Sweden has licensed one of its patents for microfluidics devices to Cellectricon, a developer of a microchip for drug discovery, the companies said today.

 

Cellectricon has used processes that are covered by the Gyros patent to develop its Dynaflow Microchip, a device for drug discovery.

 

The patent, "Microfluidic structure and process for its manufacture," was granted in the USin December 1994 (Patent No. 5,376,252), and also has corresponding worldwide patents, according to Gyros. It covers microfluidic structures with two stable base layers and an elastic spacer in between.

 

This new agreement is one of many that Gyros is pursuing, said company executives. Gyros recently announced a similar licensing agreement with Fluidigm, of South San Francisco, Calif.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.